Elevai Labs Inc. (ELAB)
NASDAQ: ELAB · Real-Time Price · USD
0.0206
-0.0008 (-3.74%)
Nov 21, 2024, 1:42 PM EST - Market open
Company Description
Elevai Labs Inc., a skincare development company, designs, manufactures, and markets skincare products in the United States.
The company offers Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions.
It serves dermatologists, plastic surgeons, medical spa owners, and physicians focused on aesthetic and therapeutic skincare.
The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021.
Elevai Labs Inc. was incorporated in 2020 and is based in Newport Beach, California.
Elevai Labs Inc.
| Country | United States |
| Founded | 2020 |
| IPO Date | Nov 21, 2023 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 18 |
| CEO | Graydon Bensler |
Contact Details
Address: 120 Newport Center Drive, Suite 250 Newport Beach, California 92660 United States | |
| Phone | 866-794-4940 |
| Website | elevaiskincare.com |
Stock Details
| Ticker Symbol | ELAB |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001840563 |
| ISIN Number | US28622K1043 |
| Employer ID | 85-1399981 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Graydon Bensler C.F.A. | Chief Executive Officer, Chief Financial Officer, Secretary and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 14, 2024 | 10-Q | Quarterly Report |
| Nov 13, 2024 | 8-K | Current Report |
| Nov 4, 2024 | SC TO-I/A | Filing |
| Oct 31, 2024 | 8-K | Current Report |
| Oct 25, 2024 | 8-K | Current Report |
| Oct 24, 2024 | 8-K | Current Report |
| Oct 9, 2024 | DEF 14C | Filing |
| Oct 4, 2024 | SC TO-I | Filing |
| Oct 3, 2024 | 8-K | Current Report |